Example of alemtuzumab concentrations in patient treated with intravenous antibody. After an initial dose escalation, 30 mg of alemtuzumab was administered 3 times a week for 8 weeks (•). Serum samples were taken before (▵) and after (▾) the dose once a week. This patient made a good clinical response to the therapy.